Docetaxel-Loaded Hyaluronic Acid-Cathepsin B-Cleavable-Peptide-Gold Nanoparticles for the Treatment of Cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gotov, Oyuntuya | - |
dc.contributor.author | Battogtokh, Gantumur | - |
dc.contributor.author | Ko, Young Tag | - |
dc.date.available | 2020-02-27T09:41:00Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2018-10 | - |
dc.identifier.issn | 1543-8384 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/3272 | - |
dc.description.abstract | Gold nanoparticles are commonly used for medical applications such as drug delivery and as therapeutic and diagnostic materials because of their unique properties. In this study, we prepared docetaxel (DTX)-loaded hyaluronic acid-cleavable-peptide gold nanoparticles for the treatment of cancer by selectively delivering DTX into the tumor and, thus, enhancing the therapeutic effect of DTX; further, we determined synergistic effects of the nanoparticles using laser treatment. The DTX-loaded hyaluronic acid-cleavable-peptide-gold nanoparticles prepared in this study had an average size of 75 nm and negative surface charge. The nanoparticles revealed greater cytotoxicity and higher tumor suppression efficacy in tumor models than free DTX under near-infrared laser irradiation. Therefore, the nanoparticle formulation prepared in this study could be utilized for targeted drug delivery and in combination with other cancer therapies. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.relation.isPartOf | MOLECULAR PHARMACEUTICS | - |
dc.subject | DRUG-DELIVERY CARRIERS | - |
dc.subject | ANTICANCER DRUG | - |
dc.subject | IN-VITRO | - |
dc.subject | THERAPY | - |
dc.subject | DOXORUBICIN | - |
dc.subject | CD44 | - |
dc.subject | THERAPEUTICS | - |
dc.subject | DESIGN | - |
dc.subject | CELLS | - |
dc.title | Docetaxel-Loaded Hyaluronic Acid-Cathepsin B-Cleavable-Peptide-Gold Nanoparticles for the Treatment of Cancer | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000446413400035 | - |
dc.identifier.doi | 10.1021/acs.molpharmaceut.8b00640 | - |
dc.identifier.bibliographicCitation | MOLECULAR PHARMACEUTICS, v.15, no.10, pp.4668 - 4676 | - |
dc.identifier.scopusid | 2-s2.0-85053640721 | - |
dc.citation.endPage | 4676 | - |
dc.citation.startPage | 4668 | - |
dc.citation.title | MOLECULAR PHARMACEUTICS | - |
dc.citation.volume | 15 | - |
dc.citation.number | 10 | - |
dc.contributor.affiliatedAuthor | Gotov, Oyuntuya | - |
dc.contributor.affiliatedAuthor | Battogtokh, Gantumur | - |
dc.contributor.affiliatedAuthor | Ko, Young Tag | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | biopolymer coating | - |
dc.subject.keywordAuthor | gold nanoparticles | - |
dc.subject.keywordAuthor | docetaxel | - |
dc.subject.keywordAuthor | hyaluronic acid | - |
dc.subject.keywordAuthor | cleavable peptide | - |
dc.subject.keywordPlus | DRUG-DELIVERY CARRIERS | - |
dc.subject.keywordPlus | ANTICANCER DRUG | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | DOXORUBICIN | - |
dc.subject.keywordPlus | CD44 | - |
dc.subject.keywordPlus | THERAPEUTICS | - |
dc.subject.keywordPlus | DESIGN | - |
dc.subject.keywordPlus | CELLS | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.